Pathology and genetics of human prion diseases

Prions in Humans and Animals

Volumn , Issue , 2006, Pages 287-314

  Kretzschmar, Hans ^a   Parchi, Piero ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84881724182     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1515/9783110200171     Document Type: Chapter

References (161)

1. Jakob A. Über eigenartige Erkrankungen des Zentralnervensystems mit bemerkenswertem anatomischem Befunde (spastische Pseudo-sklerose-Encephalomyelopathie mit dissemi-nierten Degenerationsherden). Dtsch Z Ner-venheilkd 1921; 70:132-146.
2. Spielmeyer W Histopathologie des Nervensys-tems. Springer-Verlag, Berlin, 1922.
3. Creutzfeldt HG. Über eine eigenartige herdför-mige Erkrankung des Zentralnervensystems. Z Ges Neurol Psychiatr 1920; 57:1-18.
4. Jakob A. Spastische Pseudosklerose. In: Jakob A, editor. Die extrapyramidalen Erkrankungen. Springer-Verlag, Berlin, 1923:215-245.
5. Meggendorfer F. Klinische und genealogische Beobachtungen bei einem Fali von spastischer Pseudosklerose. Z Ges Neurol Psychiatr 1930: 128:337-341.
6. Hadlow WJ. Scrapie and kuru. Lancet 1959: 2:289-290.
7. Klatzo I, Gajdusek DC, Zigas V. Pathology of the kuru. Lab Invest 1959; 8:799-847.
8. Parchi P, Giese A, Capellari S, et al. Classifi-cation of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999; 46(2):224-233.
9. Notari S, Capellari S, Giese A, et al. Effects of different experimental conditions on the PrPSc core generated by protease digestion: implica-tions for strain typing and molecular classifica-tion of CJD. J Biol Chem 2004; 279(16):16797-16804.
10. Masters CL, Richardson EP Jr. Subacute spongiform encephalopathy (Creutzfeldt-Jakob disease). The nature and progression of spongiform change. Brain 1978; 101:333-344.
11. Ferrer I, Casas R, Rivera R. Parvalbumin-im-munoreactive cortical neurons in Creutzfeldt-Jakob disease. Ann Neurol 1993; 34:864-866.
12. Guentchev M, Hainfellner J-A, Trabattoni GR. et al. Distribution of parvalbumin-immuno-reactive neurons in brain correlates with hippo-campal and temporal cortical pathology in Creutzfeldt-Jakob disease. J Neuropathol Exp Neurol 1997; 56:1119-1124.
13. Tschampa HJ, Herms JW, Schulz-Schaeffer WJ. et al. Clinicai fmdings in sporadic Creutzfeldt-Jakob disease correlate with thalamic pathology. Brain 2002; 125(11):2558-2566.
14. Steriade M and Contreras D. Spike-wave com-plexes and fast components of cortically gener-ated Scizures. I. Role of neocortex and thalamus. J Neurophysiol 1998; 80(3):1439-1455.
15. Kitamoto T, Ogomori K, Tateishi J, et al. For-mic acid pretreatment enhances immunostain-ing of cerebral and systemic amyloids. Lab Invest 1987; 57:230-236.
16. Brown P, Wolff A, Gajdusek DC. A simple and effective method for inactivating virus infectiv-ity in formalin-fixed tissue samples from patients with Creutzfeldt-Jakob disease. Neurology 1990; 40:887-890.
17. Kitamoto T, Shin RW, Doh-ura K, et al. Ab-normal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease. Am J Pathol 1992; 140:1285-1294.
18. Taraboulos A, Jendroska K, Serban D, et al. Regional mapping of prion proteins in brains. Proc Natl Acad Sci U S A 1992; 89:7620-7624.
19. Schulz-Schaeffer WJ, Tschoke S, Kranefuss N. et al. The paraffm-embedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases. Am J Pathol 2000; 156(l):51-56.
20. Jeffrey M, Goodbrand IA, Goodsir CM. Pa-thology of the transmissible spongiform en-cephalopathies with special emphasis on ultra-strueture. Micron 1995; 26(3):277-298.
21. Marsh RF, Sipe JC, Morse SS, et al. Transmissible mink encephalopathy. Reduced spongiform degeneration in aged mink of the Chediak-Higashi genotype. Lab Invest 1976: 34:381-386.
22. Baringer JR, Bowman KA, Prusiner SB. Rep-lication of the scrapie agent in hamster brain precedes neuronal vacuolation. J Neuropathol Exp Neurol 1983; 42:539-547.
23. Bruce ME. Agent replication dynamics in a long incubation period model of mouse scrapie. J GenVirol 1985; 66:2517-2522.
24. Bundza A and Charlton KM. Comparison of spongiform lesions in experimental scrapie and rabies in skunks. Acta Neuropathol 1988; 76:275-280.
25. Mallucci G, Dickinson A, Linehan J, et al. De-pleting neuronal PrP in prion infection prevenis disease and reverses spongiosis. Science 2003; 302(5646):871-874.
26. David-Ferreira JF, David-Ferreira KL, Gibbs CJ Jr, et al. Scrapie in mice: ultrastructural ob-servations in the cerebral cortex. Proc Soe Exp Biol Med 1968; 127:313-320.
27. Liberski PP, Budka H, Sluga E, et al. Tubulo-vesicular struetures in human and experimental Creutzfeldt-Jakob disease. Eur J Epidemiol 1991; 7:551-555.
28. Liberski PP, Jeffrey M, Goodsir C. Tubu-lovesicular struetures are not labeled using anti-bodies to prion protein (PrP) with the im-munogold electron microscopy techniques. Acta Neuropathol 1997; 93(3):260-264.
29. Head MW, Northcott V, Rennison K, et al. Prion protein accumulation in eyes of patients with sporadic and variant Creutzfeldt-Jakob disease. Invest Ophthalmol Vis Sci 2003: 44(l):342-346.
30. Haik S, Faucheux BA, Sazdovitch V, et al. The sympathetic nervous system is involved in vari-ant Creutzfeldt-Jakob disease. Nat Med 2003: 9(9):1121-1123.
31. Hill AF, Zeidler M, Ironside J, et al. Diag-nosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 1997; 349:99-100.
32. Wadsworth JD, Joiner S, Hill AF, et al. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet 2001; 358(9277):171-180.
33. Ghani AC, Donnelly CA, Ferguson NM, et al. Assessment of the prevalence of vCJD through testing tonsils and appendices for abnormal prion protein. Proc R Soe Lond B Biol Sci 2000; 267(1438):23-29.
34. Llewelyn CA, Hewitt PE, Knight RS, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004; 363(9407):417-421.
35. Glatzel M, Abela E, Maissen M, et al. Ex-traneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. N Engl J Med 2003: 349(19):1812-1820.
36. Koperek O, Kovacs GG, Ritchie D, et al. Disease-associated prion protein in vessel walls. Am J Pathol 2002; 161(6):1979-1984.
37. Brown P, Gibbs CJ Jr, Rodgers Johnson P, et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 1994; 35:513-529.
38. Kretzschmar HA, Stowring LE, Westaway D. et al. Molecular cloning of a human prion pro-tein cDNA. DNA 1986; 5:315-324.
39. Kretzschmar HA, Prusiner SB, Stowring LE. et al. Scrapie prion proteins are synthesized in neurons. Am J Pathol 1986; 122:1-5.
40. Moser M, Colello RJ, Pott U, et al. Develop-mental expression of the prion protein gene in glial cells. Neuron 1995; 14:509-517.
41. Hornshaw MP, McDermott JR, Candy JM, et al. Copper binding to the N-terminal tandem repeat region of mammalian and avian prion protein: structural studies using synthetic pep-tides. Biochem Biophys Res Commun 1995: 214(3):993-999.
42. Brown DR, Qin K, Herms JW, et al. The cellular prion protein binds copper in vivo. Nature 1997; 390:684-687.
43. Herms JW, Tings T, Madlung A, et al. The prion protein is predominantly localized in presynap-tiemembranes. Neurobiol Aging 1998; 19:299.
44. Herms J, Tings T, Gall S, et al. Evidence of presynaptic location and function of the prion protein. J Neurosci 1999; 19(20):8866-8875.
45. Renner C, Fiori S, Fiorino F, et al. Micellar environments induce structuring of the N-ter-minal tail of the prion protein. Biopolymers 2004; 73(4):421-433.
46. Parchi P, Capellari S, Chen SG et al. Typing prion isoforms. Nature 1997; 386(6622):232-234.
47. Parchi P, Castellani R, Capellari S, et al. Mol-ecular basis of phenotypic variability in spor-adic Creutzfeldt-Jakob disease. Ann Neurol 1996; 39(6):767-778.
48. Parchi P, Zou W, Wang W, et al. Genetic influ-ence on the structural variations of the abnor-mal prion protein. Proc Natl Acad Sci USA 2000; 97(18):10168-10172.
49. Monari L, Chen SG, Brown P, et al. Fatal fam-ilial insomnia and familial Creutzfeldt-Jakob disease: different prion proteins determined by a DNA polymorphism. Proc Natl Acad Sci USA 1994; 91(7):2839-2842.
50. Collinge J, Sidle KC, Meads J, et al. Molecular analysis of prion strain variation and the aeti-ology of 'new variant' CJD. Nature 1996: 383:685-690.
51. Petersen RB, Parchi P, Richardson SL, et al. Effect of the D178N mutation and the codon 129 polymorphism on the metabolism of the prion protein. J Biol Chem 1996; 271:12661-12668.
52. Capellari S, Parchi P, Russo CM, et al. Effect of the E200K mutation on prion protein me-tabolism. Comparative study of a cell model and human brain. Am J Pathol 2000; 157(2):613-622.
53. Wadsworth JD, Hill AF, Joiner S, et al. Strain-specificprion-protein conformation determined by metal ions. Nat Cell Biol 1999; l(l):55-59.
54. Zanusso G, Farinazzo A, Fiorini M, et al. pH-dependent prion protein conformation in clas-sical Creutzfeldt-Jakob disease. J Biol Chem 2001; 276(44):40377-40380.
55. Puoti G, Giaccone G, Rossi G, et al. Sporadic Creutzfeldt-Jakob disease: co-occurrence of different types of PrP(Sc) in the same brain. Neurology 1999; 53(9):2173-2176.
56. Kovacs GG, Head MW, Hegyi I, et al. Im-munohistochemistry for the prion protein: comparison of different monoclonal antibodies in human prion disease subtypes. Brain Pathol 2002; 12(1):1-11.
57. Head MW, Bunn TJ, Bishop MT, et al. Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: UK cases 1991-2002. Ann Neurol 2004; 55(6):851-859.
58. Polymenidou M, Stoeck K, Glatzel M, et al. Coexistence of multiple PrPSc types in individ-uais with Creutzfeldt-Jakob disease. Lancei Neurol 2005; 4(12):805-814.
59. Yull HM, Ritchie DL, Langeveld JP, et al. Detection of type 1 prion protein in variant Creutzfeldt-Jakob disease. Am J Pathol 2006; 168(1):151-157.
60. Zou WQ, Capellari S, Parchi P, et al. Identifica-tion of novel proteinase K-resistant C-terminal fragments of PrP in Creutzfeldt-Jakob disease. J Biol Chem 2003; 278(42):40429-40436.
61. Wu Y, Brown WT, Robakis NK, et al. A PvuII RFLP detected in the human prion protein (PrP) gene. Nucleic Acids Res 198715:3191.
62. Hsiao K, Dlouhy SR, Farlow MR, et al. Mu-tant prion proteins in Gerstmann-Stráussler-Scheinker disease with neurofibrillary tangles. Nat Genet 1992; 1:68-71.
63. Jeong BH, Nam JH, Lee YJ, et al. Polymor-phisms of the prion protein gene (PRNP) in a Korean population. J Hum Genet 2004; 49:319-324.
64. Palmer MS, Mahal SP, Campbell TA, et al. De-letions in the prion protein gene are not asso-ciated with CJD. Hum Mol Genet 1993; 2:541-544.
65. Beck JA, Mead S, Campbell TA, et al. Two-octapeptide repeat deletion of prion protein as-sociated with rapidly progressive dementia. Neurology 2001; 57(2):354-356.
66. Capellari S, Parchi P, Wolff BD, et al. Creutz-feldt-Jakob disease associated with a deletion of two repeats in the prion protein gene. Neuro-logy 2002; 59(10):1628-1630.
67. Laplanche JL, Delasnerie-Lauprêtre N, Bran-del JP, et al. Molecular genetics of prion diseases in France. Neurology 1994; 44:2347-2351.
68. Palmer MS, Dryden AJ, Hughes JT, et al. Homozygous prion protein genotype predis-poses to sporadic Creutzfeldt-Jakob disease. Nature 1991; 352:340-342.
69. Salvatore M, Genuardi M, Petraroli R, et al. Polymorphisms of the prion protein gene in Italianpatients with Creutzfeldt-Jakob disease. Hum Genet 1994; 94:375-379.
70. Windl O, Dempster M, Estibeiro JP, et al. Gen-etic basis of Creutzfeldt-Jakob disease in the United Kingdom: a systematic analysis of pre-disposingmutations and allelic variations in the PRNP gene. Hum Genet 1996; 98:259-264.
71. Peden AH, Head MW, Ritchie DL, et al. Pre-clinical vCJD after blood transfusion in PRNP codon 129 heterozygous patient. Lancei 2004; 364(9433):527-529.
72. Dlouhy SR, Hsiao K, Farlow MR, et al. Link-age of Indiana kindred of Gerstmann-Sträuss-ler-Scheinker disease to prion protein gene. Nat Genet 1992; 1:64-67.
73. Goldfarb LG, Petersen RB, Tabaton M, et al. Fatal familial insomnia and familial Creutz-feldt-Jakob disease: disease phenotype deter-mined by a DNA polymorphism. Science 1992: 258:806-808.
74. Kitamoto T and Tateishi J. Human prion dis-eases with variant prion protein. Philos Trans R Soe Lond B Biol Sci 1994; 343(1306):391-398.
75. Shibuya S, Higuchi J, Shin R-W, et al. Protec-tive prion protein polymorphisms against spor-adic Creutzfeldt-Jakob disease. Lancet 1998: 351:419.
76. Mead S, Stumpf MP, Whitfield J, et al. Balanc-ing selection at the prion protein gene consist-ent with prehistoric kurulike epidemies. Science 2003; 300(5619):640-643.
77. Berr C, Richard F, Dufouil C, et al. Polymor-phism of the prion protein is associated with cognitive impairment in the elderly: The EVA study. Neurology 1998; 51:734-737.
78. Croes EA, Dermaut B, Houwing-Duistermaat JJ, et al. Early cognitive decline is associated with prion protein codon 129 polymorphism. Ann Neurol 2003; 54(2):275-276.
79. Riemenschneider M, Klopp N, Xiang W, et al. Prion protein codon 129 polymorphism and risk of Alzheimeris disease. Neurology 2004; 63(2):364-366.
80. Dermaut B, Croes EA, Rademakers R, et al PRNP Vall29 homozygosity increases risk for early-onset Alzheimeris disease. Ann Neurol 2003; 53(3):409-412.
81. Parchi P, Giese A, Capellari S, et al. The mol-ecular and clinico-pathologic spectrum of phenotypes of sporadic Creutzfeldt-Jakob dis-ease (sCJD). Neurology 1998; 50:A336.
82. Telling GC, Parchi P, DeArmond SJ, et al. Evi-dence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 1996; 274:2079-2082.
83. Zerr I, Pocchiari M, Collins S, et al. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology 2000; 55(6):811-815.
84. Mizutani T, Okumura A, Oda M, et al. Panen-cephalopathic type of Creutzfeldt-Jakob dis- ease: primary involvement of the cerebral white matter. J Neurol 1981; 44:103-115.
85. Ghorayeb I, Series C, Parchi P, et al. Creutz-feldt-Jakob disease with long duration and panencephalopathic lesions: Molecular analysis of one case. Neurology 1998; 51:271-274.
86. Deslys J-P, Jaegly A, d'Aignaux JH, et al. Geno-type at codon 129 and susceptibility to Creutzfeldt-Jakob disease. Lancet 1998; 351:1251.
87. Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996; 347:921-925.
88. Ironside JW, McCardle L, Horsburgh A, et al. Pathological diagnosis of variant Creutzfeldt-Jakob disease. APMIS 2002; 110(l):79-87.
89. Houston F, Foster JD, Chong A, et al. Trans-mission of BSE by blood transfusion in sheep. Lancet 2000; 356(9234):999-1000.
90. Bruce ME, Will RG, Ironside JW, et al. Trans-missions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 1997: 389:489-501.
91. Scott MR, Will R, Ironside J, et al. Compelling transgenetic evidence for transmission of bov-ine spongiform encephalopathy prions to humans. Proc Natl Acad Sci U S A 1999: 96(26):15137-15142.
92. Gajdusek DC, Gibbs CJ Jr, Alpers M. Experi-mental transmission of a kuru-like syndrome to chimpanzees. Nature 1966; 209:794-796.
93. Krucke W, Beck E, Vitzthum HG. Creutzfeldt-Jakob disease. Some unusual morphological features reminiscent of kuru. Z Neurol 1973; 206(l):l-24.
94. Beck E, Daniel PM, Alpers M, et al. Neuro-pathological comparisons of experimental kuru in chimpanzees with human kuru. Int Arch Al-lergy Immunol 1969; 36:553-562.
95. Cervenáková L, Goldfarb LG, Garruto R, et al. Phenotype-genotype studies in kuru: Impli-cations for new variant Creutzfeldt-Jakob disease. Proc Natl Acad Sci USA 1998; 95:13239-13241.
96. Puoti G, Limido L, Cotrufo R, et al. Sporadic Creutzfeldt-Jakob disease with MMl-type prion protein and plaques. Neurology 2004; 62(7):1239.
97. Gerstmann J. Über ein noch nicht be-schriebenes Reflexphänomen bei einer Erkran-kung des zerebelláren Systems. Wien Med Wochenschr 1928; 78:906-908.
98. Gerstmann J, Stráussler E, Scheinker I. Úber eine eigenartige hereditár-familiáre Erkran-kung des Zentralnervensystems. Zugleich ein Beitrag zur Frage des vorzeitigen lokalen Alteras. Z Neurol 1936; 154:736-762.
99. De Michele G, Pocchiari M, Petraroli R, et al. Variable phenotype in a P102L Gerstmann-Stráussler-Scheinker Italian family. Can J Neurol Sci 2003; 30(3):233-236.
100. Barbanti P, Fabbrini G, Salvatore M, et al. Polymorphism at codon 129 or codon 219 of PRNP and clinicai heterogeneity in a previous-ly unreported family with Gerstmann-Stráus-sler-Scheinker disease (PrP-P102L mutation). Neurology 1996; 47(3):734-741.
101. Tanaka Y, Minematsu K, Moriyasu H, et al. A Japanese family with a variant of Gerstmann-Stráussler-Scheinker disease. J Neurol Neuro-surg Psychiatry 1997; 62(5):454-457.
102. Tateishi J, Brown P, Kitamoto T, et al. First experimental transmission of fatal familial in-somnia. Nature 1995; 376:434-435.
103. Mastrianni JA, Nixon R, Layzer R, et al. Brief report: Prion protein conformation in a patient with sporadic fatal insomnia. N Engl J Med 1999; 340(21):1630-1638.
104. Collinge J, Palmer MS, Sidle KCL, et al. Transmission of fatal familial insomnia to laboratory animais. The Lancet 1995; 346:569-570.
105. Scott MRD, Telling GC, Prusiner SB. Trans-geneties and gene targeting in studies of prion diseases. In: Prusiner SB, editor. Prions. Prions. Prions. Springer-Verlag, Berlin, 1996:95-123.
106. Zerr I, Bodemer M, Gefeller O, et al. Detection of 14-3-3 protein in the cerebrospinal fluid sup-ports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol 1998; 43:32-38.
107. Kretzschmar H, Giese A, Zerr I, et al. The Ger-man FFI cases. Brain Pathol 1998; 8:559-561.
108. ZerrI, Giese A, WindlO, etal. Phenotypicvaria-bility in fatal familial insomnia (D178N-129M) genotype. Neurology 1998; 51:1398-1405.
109. Parchi P, Capellari S, Chin S, et al. A subtype of sporadic prion disease mimicking fatal fam-ilial insomnia. Neurolgy 1999; 52:1757-1763.
110. Scaravilli F, Cordery RJ, Kretzschmar H, et al. Sporadic fatal insomnia: a case study. Ann Neurol 2000; 48(4):665-668.
111. Collinge J, Owen F, Poulter M, et al. Prion de-mentia without characteristic pathology. Lancet 1990; 336:7-9.
112. Lugaresi E, Medori R, Montagna P, et al. Fatal familial insomnia and dysautonomia with selec-tive degeneration of thalamic nuclei. N Engl J Med 1986; 315:997-1003.
113. Medori R Tritschler H-J, LeBlanc A, et al. Fatal familial insomnia, a prion disease with mutation at codon 178 of the prion protein gene. N Engl J Med 1992; 326:444-49.
114. Kretzschmar HA, Neumann M, Stavrou D. Codon 178 mutation of the human prion pro-tein gene in a German family (Backer family): sequencing data from 72-year-old celloidin-em-bedded brain tissue. Acta Neuropathol (Berl) 1995; 89:96-98.
115. Masters CL and Gajdusek DC. The spectrum of Creutzfeldt-Jakob disease and the virus-in-duced subacute spongiform encephalopathies. Recent Adv Neuropathol 1982; 2:139-163.
116. Hsiao K, Baker HF, Crow TJ, et al. Linkage of a prion protein missense variant to Ger-stmann-Stráussler syndrome. Nature 1989: 338:342-345.
117. Gabizon R, Rosenmann H, Meiner Z, et al. Mutation and polymorphism of the prion pro-tein gene in Libyan Jews with Creutzfeldt-Jakob disease (CJD). American Journal of Human Genetics 1993; 53:828-835.
118. Kahana E, Alter M, Braham J, et al. Creutz-feldt-Jakob disease: focus among Libyan Jews in Israel. Science 1974; 183:90-91.
119. Goldfarb LG, Korczyn AD, Brown P, et al. Mutation in codon 200 of scrapie amyloid precursor gene linked to Creutzfeldt-Jakob disease in Sephardic Jews of Libyan and non-Libyan ori-gin. Lancet 1990; 336:637-638.
120. Goldfarb LG, Mitrová E, Brown P, et al. Mu-tation in codon 200 of scrapie amyloid protein gene in two clusters of Creutzfeldt-Jakob dis-ease in Slovakia. Lancet 1990; 336:514-515.
121. Goldfarb LG, Brown P, Mitrowá E, et al. Creutzfeldt-Jakob disease associated with the PRNP codon 200 Lys mutation. An analysis of 45 families. Eur J Epidemiol 1991; 7:477-486.
122. Kretzschmar HA, Honold G, Scitelberger F, et al. Prion protein mutation in family first re-ported by Gerstmann, Stráussler, and Scheinker. Lancet 1991; 337:1160.
123. Masters CL, Gajdusek DC, Gibbs CJ Jr. Creutzfeldt-Jakob disease virus isolations from the Gerstmann-Stráussler syndrome. With an analysis of the various forms of amyloid plaque deposition in the virus-induced spongiform en-cephalopathies. Brain 1981; 104:559-588.
124. Tateishi J, Sato Y, Nagara H, et al. Experimen-tal transmission of human subacute spongiform encephalopathy to small rodents. IV. positive transmission from a typical case of Gerstmann-Stráussler-Scheinker disease. Acta Neuropathol (Berl) 1984; 64:85-88.
125. Hsiao K, Scott M, Foster D, et al. Spontaneous neurodegeneration in transgenic mice with mu-tant prion protein. Science 1990; 250:1587-1590.
126. Hsiao K, Groth D, Scott M, et al. Serial trans-mission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein. Proc Natl Acad Sci USA 1994; 91:9126-9130.
127. Manson JC, Jamieson E, Baybutt H, et al. A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encepha-lopathy. EMBO J 1999; 18(23):6855-6864.
128. Goldfarb LG, Brown P, McCombie WR, et al. Transmissible familial Creutzfeldt-Jakob dis-ease associated with five, seven, and eight extra octapeptide coding repeats in the PRNP gene. ProcNatlAcadSciUSA1991;88:10926-10930.
129. Collinge J, Brown J, Hardy J, et al. Inherited prion disease with 144 base pair gene insertion. 2. Clinicai and pathological features. Brain 1992; 115:687-710.
130. Gambetti P, Kong Q, Zou W, et al. Sporadic and familial CJD: classification and character-isation. Br Med Buli 2003; 66:213-239.
131. Kretzschmar HA, Sethi S, Foldvari Z, et al. Iatrogenic Creutzfeldt-Jakob disease with florid plaques. Brain Pathol 2003; 13(3):245-249.
132. Kopp N, Streichenberger N, Deslys JP, et al. Creutzfeldt-Jakob disease in a 52-year-old woman with florid plaques. Lancet 1996; 348:1239-1240.
133. Deslys JP, Lasmézas Cl, Streichenberger N, et al. New variant Creutzfeldt-Jakob disease in France. Lancet 1997; 349:30-31.
134. Takashima S, Tateishi J, Taguchi Y, et al. Creutzfeldt-Jakob disease with florid plaques after cadaveric durai graft in a Japanese woman. Lancet 1997; 350:865-866.
135. Shimizu S, Hoshi K, Muramoto T, et al. Creutzfeldt-Jakob disease with florid-type plaques after cadaveric dura mater grafting. Arch Neurol 1999; 56:357-362.
136. Skworc KH, Windl O, Schulz-Schaeffer WJ, et al. Familial Creutzfeldt-Jakob disease with a novel 120-bp insertion in the prion protein gene. Ann Neurol 1999; 46(5):693-700.
137. Itoh Y, Yamada M, Hayakawa M, et al. A variant of Gerstmann-Sträussler-Scheinker disease carrying codon 105 mutation with codon 129 polymorphism of the prion protein gene: a clinicopathological study. J Neurol Sci 1994: 127:77-86.
138. Mastrianni JA, Curtis MT, Oberholtzer JC, et al. Prion disease (PrP-A117V) presenting with ataxia instead of dementia. Neurology 1995; 45:2042-2050.
139. Tranchant C, Sergeant N, Wattez A, et al. Neurofibrillary tangles in Gerstmann-Sträussler-Scheinker syndrome with the Al 17V prion gene mutation. J Neurol Neurosurg Psychiatry 1997: 63:240-246.
140. Ghetti B, Piccardo P, Spillantini MG, et al. Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: The phenotype of the stop codon 145 mutation in PRNP. Proc Natl Acad Sci USA 1996; 93:744-748.
141. Kitamoto T, Iizuka R, Tateishi J. An amber mutation of prion proteininGerstmann-Sträussler syndrome with mutant PrP plaques. Biochem Biophys Res Commun 1993; 192:525-531.
142. Samaia HB, Mari JD, Vallada HP, et al. A prionlinked psychiatric disorder. Nature 1997; 390:241.
143. Gambetti P, Parchi P, Petersen RB, et al. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: clinicai, pathological and molecular features. Brain Pathol 1995; 5:43-51.
144. Ishida S, Sugino M, Koizumi N, et al. Serial MRI in early Creutzfeldt-Jakob disease with a point mutation of prion protein at codon 180. Neuroradiology 1995; 37:531-534.
145. Kitamoto T, Ohta M, Dohura K, et al. Novel missense variants of prion protein in Creutz-feldt-Jakob disease or Gerstmann-Sträussler syndrome. Biochem Biophys Res Commun 1993; 191:709-714.
146. Nitrini R, Rosemberg S, Passos-Bueno MR, et al. Familial spongiform encephalopathy associated with a novel prion protein gene mutation. Ann Neurol 1997; 42:138-146.
147. Grasbon-Frodl EM, Lorenz H, Mann U, et al. Loss of glycosylation associated with the T183A mutation in human prion disease. Acta Neuropath 2004; 108(6):476-484.
148. Ghetti B, Dlouhy SR, Giaccone G, et al. Gerst-mann-Sträussler-Scheinker disease and the In-diana kindred. Brain Pathol 1995; 5:61-75.
149. Chapman J, Arlazoroff A, Goldfarb LG, et al. Fatal insomnia in a case of familial Creutzfeldt-Jakob disease with the codon 200Lys mutation. Neurology 1996; 46:758-761.
150. Mastrianni JA, Iannicola C, Myers RM, et al. Mutation of the prion protein gene at codon 208 in familial Creutzfeldt-Jakob disease. Neurology 1996; 47:1305-1312.
151. Roeber S, Krebs B, Neumann M, et al. Creutz-feldt-Jakob disease in a patient with an R208H mutation of the prion protein gene (PRNP) and a 17-kDa prion protein fragment. Acta Neuro-pathol (Berl) 2005; 109(4):443-448.
152. Pocchiari M, Salvatore M, Cutruzzolá F, et al. A new point mutation of the prion protein gene in Creutzfeldt-Jakob disease. Ann Neurol 1993; 34:802-807.
153. Ripoll L, Laplanche JL, Salzmann M, et al. A new point mutation in the prion protein gene at codon 210 in Creutzfeldt-Jakob disease. Neurology 1993; 43:1934-1937.
154. Mastrianni JA, Capellari S, Telling GC, et al. Inherited prion disease caused by the V210I mutation: Transmission to transgenic mice. Neurology 2001; 57(12):2198-2205.
155. Young K, Piccardo P, Kish SJ, et al. Gerst-mann-Stráussler-Scheinker disease (GSS) with a mutation at prion protein (PrP) residue 212. J Neuropathol Exp Neurol 1998; 57:518.
156. Hoque MZ, Kitamoto T, Furukawa H, et al. Mutation in the prion protein gene at codon 232 in Japanese patients with Creutzfeldt-Jakob disease: a clinicopathological, im- munohistochemical and transmission study. Acta Neuropathol 1996; 92(5):441-446.
157. Pastore M, Castellani R, Chin S, et al. Creutz-feldt-Jakob disease associated with the novel R148H prion protein gene mutation. J Neuro-pathol Exp Neurol 2002; 61:491.
158. Collins S, Boyd A, Fletcher A, et al. Novel prion protein gene mutation in an octogenarian with Creutzfeldt-Jakob disease. Arch Neurol 2000; 57(7):1058-1063.
159. Peoc'h K, Manivet P, Beaudry P, et al. Identi-fication of three novel mutations (E196K. V203I, E211Q) in the prion protein gene (PRNP) in inherited prion diseases with Creutz-feldt-Jakob disease phenotype. Hum Mutat 2000; 15(5):482.
160. Ladogana A, Almonti S, Petraroli R et al. Mu-tation of the PRNP gene at codon 211 in fam-ilial Creutzfeldt-Jakob disease. Am J Med Gen-et 2001; 103(2):133-137.
161. Finckh U, Muller-Thomsen T, Mann U, et al. Highprevalenceofpathogenicmutationsin pa-tients with early-onset dementia detected by se-quence analyses of four different genes. Am J Hum Genet 2000; 66(1):110-117.